118 related articles for article (PubMed ID: 38585253)
1. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling [LETTER].
Pasiana AD; Idrus HH; Purnamasari I
Drug Des Devel Ther; 2024; 18():1023-1024. PubMed ID: 38585253
[No Abstract] [Full Text] [Related]
2. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.
Liu J; Fang G; Lan C; Qiu C; Yao L; Zhang Q; Hu J; Zhang Y; Yang Y; Zhang Y
Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631
[TBL] [Abstract][Full Text] [Related]
3. Srolo Bzhtang reduces inflammation and vascular remodeling via suppression of the MAPK/NF-κB signaling pathway in rats with pulmonary arterial hypertension.
Chen T; Su S; Yang Z; Zhang D; Li Z; Lu D
J Ethnopharmacol; 2022 Oct; 297():115572. PubMed ID: 35872290
[TBL] [Abstract][Full Text] [Related]
4. Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways.
Yu M; Wu X; Wang J; He M; Han H; Hu S; Xu J; Yang M; Tan Q; Wang Y; Wang H; Xie W; Kong H
Int J Med Sci; 2022; 19(4):681-694. PubMed ID: 35582418
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
[TBL] [Abstract][Full Text] [Related]
6. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats.
Tang C; Luo Y; Li S; Huang B; Xu S; Li L
Biomed Pharmacother; 2021 Jan; 133():111081. PubMed ID: 33378977
[TBL] [Abstract][Full Text] [Related]
8. 18β-Glycyrrhetinic acid ameliorates endoplasmic reticulum stress-induced inflammation in pulmonary arterial hypertension through PERK/eIF2α/NF-κB signaling.
Wang JL; Liu H; Jing ZC; Zhao F; Zhou R
Chin J Physiol; 2022; 65(4):187-198. PubMed ID: 36073567
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M
Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628
[TBL] [Abstract][Full Text] [Related]
10. eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.
Guo L; Li Y; Tian Y; Gong S; Chen X; Peng T; Wang A; Jiang Z
Drug Des Devel Ther; 2019; 13():2799-2809. PubMed ID: 31496656
[TBL] [Abstract][Full Text] [Related]
11. AOS ameliorates monocrotaline-induced pulmonary hypertension by restraining the activation of P-selectin/p38MAPK/NF-κB pathway in rats.
Hu Y; Feng Z; Feng W; Hu T; Guan H; Mao Y
Biomed Pharmacother; 2019 Jan; 109():1319-1326. PubMed ID: 30551382
[TBL] [Abstract][Full Text] [Related]
12. Caffeic Acid Phenethyl Ester Rescues Pulmonary Arterial Hypertension through the Inhibition of AKT/ERK-Dependent PDGF/HIF-1α In Vitro and In Vivo.
Cheng CC; Chi PL; Shen MC; Shu CW; Wann SR; Liu CP; Tseng CJ; Huang WC
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909527
[TBL] [Abstract][Full Text] [Related]
13. Effects of masitinib compared with tadalafil for the treatment of monocrotaline-induced pulmonary arterial hypertension in rats.
Leong ZP; Hikasa Y
Vascul Pharmacol; 2019; 122-123():106599. PubMed ID: 31629919
[TBL] [Abstract][Full Text] [Related]
14. Grape seed proanthocyanidin reverses pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension by down-regulating HSP70.
Chen F; Wang H; Yan J; Lai J; Cai S; Yuan L; Zheng S
Biomed Pharmacother; 2018 May; 101():123-128. PubMed ID: 29482057
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension.
Xu T; Liu S; Ma T; Jia Z; Zhang Z; Wang A
Redox Biol; 2017 Apr; 11():286-296. PubMed ID: 28030785
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway.
Liu JX; Li X; Yan FG; Pan QJ; Yang C; Wu MY; Li G; Liu HF
Int Immunopharmacol; 2019 Jan; 66():336-346. PubMed ID: 30521962
[TBL] [Abstract][Full Text] [Related]
17. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
[TBL] [Abstract][Full Text] [Related]
18. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.
Price LC; Shao D; Meng C; Perros F; Garfield BE; Zhu J; Montani D; Dorfmuller P; Humbert M; Adcock IM; Wort SJ
Respir Res; 2015 Sep; 16(1):114. PubMed ID: 26382031
[TBL] [Abstract][Full Text] [Related]
20. Protective role of forsythoside B in Kawasaki disease-induced cardiac injury: Inhibition of pyroptosis via the SIRT1-NF-κB-p65 signaling pathway.
Yang Y; Wang N; Wang Z; Zhao M; Chen L; Shi Z
Chem Biol Interact; 2024 Apr; 392():110953. PubMed ID: 38471628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
